Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database (Q5977801): Difference between revisions

From MaRDI portal
Created claim: MaRDI profile type (P1460): MaRDI publication profile (Q5976449), #quickstatements; #temporary_batch_1710461149452
Added link to MaRDI item.
 
links / mardi / namelinks / mardi / name
 

Latest revision as of 15:49, 25 April 2024

scientific article
Language Label Description Also known as
English
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
scientific article

    Statements

    72
    0 references
    6
    0 references
    905-908
    0 references
    9 November 2011
    0 references
    0 references
    0 references

    Identifiers